Zacks Investment Research on MSN
Here's why you should add Inogen stock to your portfolio now
Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator ...
Inogen, Inc. INGN has been gaining on the back of its high prospects in the portable oxygen concentrator (POC) space. Solid performance in the second quarter of 2022 and a strong product portfolio ...
Inogen, in partnership with Yuwell, has taken another step toward becoming a comprehensive respiratory solutions company with ...
Inogen INGN witnessed strong momentum in the year-to-date period. Shares of the company have surged 127.1% compared with 9.1% growth of the industry. The S&P 500 composite has risen 17.4% during the ...
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction of ...
Inogen (INGN) remains unprofitable, with losses widening at a 31.9% annual rate over the past five years. Forecasts show its net profit margin is expected to stay negative for at least three more ...
Inogen has continued to struggle, with growth in the rental business overshadowed by declines in direct-to-consumer sales, volatility in business-to-business sales, and pricing pressures. Inogen has ...
Welcome to Inogen’s Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we will hold a Q&A session.
Stifel Nicolaus analyst Mathew Blackman maintained a Hold rating on Inogen (INGN - Research Report) on November 4 and set a price target of $24.00. The companys shares closed yesterday at $20.86.
Medical Technology company Inogen Inc (NASDAQ:INGN) reported a fourth-quarter adjusted EPS loss of 24 cents, compared to a loss of 83 cents a year ago, beating the consensus loss of 61 cents. The ...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results